Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report.

Frontiers in endocrinology - 1 Jan 2023

Cecchetti Carolina, Belardinelli Elisabetta, Dionese Paola, Teglia Rita, Fazzeri Roberta, D' Apice M Rosaria, Vestito Amanda, Pagotto Uberto, Gambineri Alessandra

Abstract excerpt

Background and objective: Severe metabolic complications generally manifest at an early age in Berardinelli - Seip congenital lipodystrophy (BSCL) and their management is especially challenging. Nutritional intervention with low lipid diets is considered by experts to be fundamental in treating the disease when associated with medical therapy, however little is known about the beneficial effects of dietary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet, Fat-Restricted
Share to Homozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leptin

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 37347108
DOI: 10.3389/fendo.2023.1190363
PMCID: PMC10281053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report.PMID 37347108Read ↗

Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli-Seip congenital lipodystrophy patients.Semantic proximity Read ↗

Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL).Semantic proximity Read ↗

Berardinelli Seip Congenital Lipodystrophy Syndrome: 10 Year Follow-up.Semantic proximity Read ↗

[Genetic and metabolic description of five patients with Berardinelli-Seip syndrome].Semantic proximity Read ↗

Berardinelli-Seip syndrome.Semantic proximity Read ↗

Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome.Semantic proximity Read ↗

Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction.Semantic proximity Read ↗

AGPAT2 gene mutation in a child with Berardinelli-Seip congenital lipodystrophy syndrome.Semantic proximity Read ↗

Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil.Semantic proximity Read ↗

Function of seipin: new insights from Bscl2/seipin knockout mouse models.Semantic proximity Read ↗

Berardinelli syndrome. A case report with fatal outcome.Semantic proximity Read ↗

Prevalence of mutations in AGPAT2 among human lipodystrophies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.